Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Dermatomyositis × Etanercept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 12 Leukemia 5 Spondylitis, Ankylosing 3 Psoriasis 3 Myelodysplastic Syndromes 3 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Arthritis, Psoriatic 2 Spondylarthritis 1 Respiratory Distress Syndrome 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Lung Injury 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Inflammatory Bowel Diseases 1 Infections 1 Immunoglobulin Light-chain Amyloidosis 1 Hematologic Neoplasms 1 HIV Infections 1 Gulf War Illness 1

Interventions

Sodium Chloride 1 Etanercept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00112385 2011-06-21

A Pilot Study of Etanercept in Dermatomyositis

Brigham and Women's Hospital

Phase 1 Completed

16 enrolled 42 charts

Dermatomyositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡